The Dutch biotech’s SureTACs platform targets membrane proteins that have long eluded conventional drug discovery by engineering them out of existence rather than blocking them. Biovance Capital joi [...]
Ysios Capital launches €100M fund to build biotech companies from Spanish science
Spain’s largest life sciences VC is moving upstream with InceptionBio, its first fund dedicated to the riskiest stage of biotech: company creation from university and research centre spinouts. CDTI [...]
The AI Doc explores how we can survive an uncertain AI future
Anxiety, more so than technological rigor, sits at the heart of The AI Doc: Or How I Became an Apocaloptimist. Director Daniel Roher is anxious about the future he's bringing a child into — wil [...]